GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HSPA1A, IGF1R, JAK2, KDR, MCL1, MET, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
12.1205 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HSPA1A, IGF1R, JAK2, KDR, MCL1, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
12.1205 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, HSPA1A, IGF1R, JAK2, KDR, MCL1, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
11.5861 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MCL1, MMP2, PIK3CA, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SMAD3, SRC, TEK, TRPV1 |
11.5861 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, JAK2, KDR, MCL1, MET, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK |
11.1436 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, JAK2, KDR, MCL1, MET, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK |
11.1156 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CHRM1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HSPA1A, INSR, JAK2, KCNH2, KDR, MCL1, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS1, PTGS2, SLC22A1, SLC22A2, SLC22A3, SMAD3, SRC, TEK, TRPV1, XDH |
10.8141 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, JAK2, KDR, MCL1, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
10.8141 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, JAK2, KDR, MCL1, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
10.8001 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MMP2, MMP9, PIK3CA, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SMAD3, SRC, TEK, TRPV1 |
10.5989 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, JAK2, KDR, MCL1, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK |
10.5078 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, IGF1R, INSR, JAK2, MMP2, MMP9, PIK3CA, PPARA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TEK, TRPV1 |
10.2463 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP3, FLT3, GPR35, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
10.2175 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FLT3, GPR35, HSPA1A, IGF1R, INSR, JAK2, KDR, MCL1, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH |
9.8715 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, JAK2, KDR, MCL1, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
9.47213 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AXL, BCL2, CYP1B1, EGFR, FLT3, GPR35, HSPA1A, INSR, JAK2, KDR, MCL1, MET, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH |
9.46696 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TEK, XDH |
9.05578 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, INSR, PPARA, PRKCD, PRKCE, PTGS2, SRC, TEK, TRPV1 |
9.02057 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK |
8.96736 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
8.93644 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SMAD3, SRC, TRPV1 |
8.93644 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCL2, CDC25B, CHRM1, CSNK2A1, CYP1B1, EGFR, ESR1, FABP3, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PRKCA, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
8.79241 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TEK, XDH |
8.65102 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PRKCD, PRKCE, PTGS2, SMAD3, SRC, TEK, TRPV1 |
8.65102 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MMP2, MMP9, NUAK1, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, RORC, SMAD3, SRC, TOP2A, TRPV1 |
8.65102 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, AXL, BCL2, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, EGFR, GPR35, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MET, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TRPV1 |
8.65102 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EBP, EGFR, ESR1, FABP3, FABP4, FUT7, MET, MGLL, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TBXAS1, TRPV1 |
8.56529 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, JAK2, KCNH2, MCL1, MET, PIK3CA, PIK3CB, PRKCB, PRKCE, SMAD3, SRC, TRPV1 |
8.28436 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, HSPA1A, IGF1R, INSR, JAK2, KDR, MCL1, MET, MGLL, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
8.23473 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, XDH |
8.2046 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK |
8.18377 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, HSPA1A, IGF1R, INSR, JAK2, KDR, MCL1, MET, MGLL, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
8.09742 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FABP4, FLT3, GPR35, HSPA1A, INSR, JAK2, KDR, MCL1, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
8.09389 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, PIM1, PRKCG, SRC, TEK |
7.99259 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MGLL, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1 |
7.84079 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, BCL2, CHRM1, CHRM4, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, JAK2, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK |
7.82082 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SMAD3, SRC, TRPV1 |
7.76396 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CYP19A1, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, JAK2, MCL1, MET, MGLL, MMP12, MMP2, NUAK1, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.69612 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FLT3, PRKCE, PRKCG, PTGS2, RORC, SRC, TEK, TRPV1 |
7.61295 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, JAK2, KCNH2, KDR, MCL1, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
7.29975 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC, TEK |
7.29975 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, JAK2, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK |
7.19155 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, MET, PRKCD, SRC, TEK |
7.07983 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, MET, PRKCD, SRC, TEK |
7.013 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, EGFR, GPR35, HSPA1A, INSR, JAK2, KCNH2, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TRPV1 |
6.96437 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FLT3, GPR35, HSPA1A, IGF1R, INSR, JAK2, KDR, MCL1, MET, MGLL, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.87974 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MET, MGLL, MMP1, MMP2, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SMAD3, SRC, TBXAS1, TEK, TOP2A, XDH |
6.86884 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PRKCD, PTGS2, SRC |
6.83046 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.80633 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, JAK2, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK |
6.78352 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, JAK2, MCL1, MGLL, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1 |
6.76731 |
[BP] GO:0030168 |
platelet activation
|
AXL, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
6.70791 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, JAK2, KCNH2, MET, PIK3CA, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
6.6563 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, FABP4, FLT3, FUT7, GLO1, INSR, JAK2, KDR, MCL1, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCD, PTGS2, RORC, SMAD3, SRC, TEK, TOP2A |
6.5915 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, JAK2, KDR, MCL1, MET, MGLL, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.58291 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SRC, TRPV1 |
6.57904 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, HSPA1A, JAK2, MMP9, PRKCD, PTGS1, PTGS2, SRC |
6.49537 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SMAD3, SRC, TEK |
6.45274 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KCNH2, KDR, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
6.4124 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A |
6.40311 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EBP, FABP3, FUT7, GLO1, HSPA1A, MGLL, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TBXAS1, XDH |
6.39905 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, JAK2, PRKCD, PTGS2, SMAD3, TRPV1, XDH |
6.38432 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, EGFR, FABP3, FLT3, INSR, JAK2, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.37321 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, EGFR, FABP3, FLT3, INSR, JAK2, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.37321 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CHRM1, CSNK2A1, EGFR, ESR1, FLT3, IGF1R, INSR, JAK2, KDR, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS2, TEK |
6.37321 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, JAK2, MGLL, MMP12, MMP2, PPARA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.3427 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, BCL2, CDC25B, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, JAK2, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.32128 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, JAK2, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK |
6.32128 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CHRM4, CSNK2A1, EGFR, FLT3, GPR35, IGF1R, INSR, JAK2, KDR, MCL1, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SMAD3, SRC, TEK, TRPV1 |
6.31792 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2, TBXAS1 |
6.30558 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, BCL2, CDC25B, DUSP3, EGFR, FABP3, FABP4, FLT3, IGF1R, INSR, JAK2, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.264 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, EGFR, IGF1R, INSR, JAK2, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK |
6.25588 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, APEX1, BCL2, CSNK2A1, EGFR, HSPA1A, INSR, KDR, MCL1, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3 |
6.18932 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, JAK2, PRKCD, PTGS2, SMAD3, TRPV1, XDH |
6.17645 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, JAK2, PRKCE, PTGS2, RORC, SRC |
6.12436 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, EGFR, IGF1R, INSR, JAK2, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK |
6.0855 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, JAK2, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
6.07163 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KCNH2, KDR, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TRPV1 |
6.01695 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, EGFR, FLT3, INSR, JAK2, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH |
5.99357 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, JAK2, KCNH2, KDR, MCL1, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
5.97496 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2, TBXAS1 |
5.96844 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, EGFR, IGF1R, INSR, JAK2, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK |
5.96844 |
[BP] GO:0001775 |
cell activation
|
ALOX5, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SMAD3, SRC, TRPV1 |
5.91354 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.90374 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, FABP4, FUT7, MET, MGLL, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TBXAS1 |
5.88482 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SMAD3, SRC, TEK |
5.85565 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
5.82164 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, EGFR, IGF1R, INSR, JAK2, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TEK |
5.7966 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CHRM1, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP4, IGF1R, INSR, JAK2, KCNH2, MCL1, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PRKCD, PRKCG, PTGS2, RORC, SMAD3, SRC, TEK, TRPV1 |
5.7852 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2, TBXAS1 |
5.76131 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SMAD3, SRC, TEK |
5.73759 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, EGFR, FLT3, INSR, JAK2, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH |
5.73166 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, JAK2, KDR, MET, MGLL, MMP12, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, SMAD3, TEK |
5.6739 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
5.6739 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, PRKCD, SRC |
5.64957 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TEK, XDH |
5.6003 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, JAK2, PTGS2, SMAD3, TRPV1 |
5.59939 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, JAK2, PTGS2, SMAD3, TRPV1 |
5.59939 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, JAK2, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH |
5.5864 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, JAK2, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH |
5.56481 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AXL, BCL2, CA1, CA2, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP1B1, EBP, EGFR, ESR1, ESR2, FLT3, GPR35, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MET, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1 |
5.52995 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, AXL, BCL2, CA2, CHRM1, CHRM2, CYP1B1, EGFR, ESR1, GPR35, HSPA1A, INSR, JAK2, KCNH2, KDR, MET, MGLL, MMP12, MMP9, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, SMAD3, SRC, TEK, TRPV1, XDH |
5.51868 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MET, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TEK |
5.47701 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AURKB, BCL2, CDC25B, EGFR, ESR1, ESR2, FABP3, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
5.47142 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, PIK3CB, PRKCA, PRKCD, PRKCE, PTPN1, SRC, TEK, XDH |
5.41797 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SMAD3, SRC, XDH |
5.41057 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SMAD3, SRC, TEK |
5.40791 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SMAD3, SRC, XDH |
5.39376 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, IGF1R, JAK2, MET, MMP9, PIM1, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC |
5.38443 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, XDH |
5.28903 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, JAK2, KDR, SRC |
5.27614 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, PRKCD, SRC |
5.27408 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PRKCD, PRKCE, PTGS2, SRC, TEK |
5.26986 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AURKB, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, JAK2, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.26986 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, FABP3, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
5.25249 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TEK |
5.22207 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CHRM1, CYP19A1, EGFR, INSR, JAK2, KCNH2, MMP12, PRKCD, PRKCE, PTGS2, SMAD3, SRC, TRPV1 |
5.21367 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CHRM1, CHRM4, CYP1A1, EGFR, ESR1, FLT3, MET, PIK3CB, PIM1, PRKCD, SRC, TEK |
5.15773 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, JAK2, MGLL, PPARA, PRKCD, PTGS2, SMAD3, TEK |
5.14565 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TEK, TRPV1 |
5.11834 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1 |
5.09041 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AURKB, AXL, BCL2, CDC25B, CHRM1, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH |
5.07565 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, HSPA1A, INSR, JAK2, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.07565 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CYP19A1, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, PPARA, PRKCB, PRKCD, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.06657 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, GPR35, JAK2, KCNH2, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
5.05849 |
[BP] GO:0030155 |
regulation of cell adhesion
|
BCL2, CYP1B1, DUSP3, JAK2, KDR, NUAK1, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, SMAD3, SRC, TEK |
5.05849 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, JAK2, PTGS2, SMAD3, TRPV1 |
5.05849 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, JAK2, KDR, PRKCD, PRKCE, SRC |
5.00927 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, INSR, JAK2, PTGS2, SLC22A2, SLC22A3, SMAD3, TRPV1 |
4.97608 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, JAK2, PRKCA, PRKCB, PRKCD |
4.93111 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PRKCD, SRC |
4.93111 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
4.91885 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, BCL2, CDC25B, EGFR, ESR1, FLT3, HSPA1A, INSR, JAK2, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.8766 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, JAK2, PTGS2, SMAD3, TRPV1 |
4.844 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MCL1, MMP9, PTGS2, PTPN1, SRC |
4.84371 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, JAK2, PIK3CB, PRKCD, PTPN1, SRC |
4.8247 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, EGFR, FLT3, INSR, JAK2, KDR, PIK3CB, PRKCA, PRKCE, PTPN1, SRC, TEK, XDH |
4.80421 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DUSP3, ESR1, HSPA1A, IGF1R, MCL1, MET, MMP9, PRKCD, PTGS2, PTPN1, SRC, XDH |
4.74836 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, EGFR, GPR35, JAK2, KCNH2, MGLL, PRKCA, PTGS2, SMAD3, TRPV1 |
4.7316 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SRC, TEK, TRPV1 |
4.73137 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, IGF1R, INSR, PPARA, PRKCD, PTGS2, SRC, TEK, TRPV1 |
4.72325 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2, TBXAS1 |
4.70995 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, PTGS2, RORC, SRC, TRPV1 |
4.70822 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, INSR, MET, PIK3CA, PIK3CB, SRC, TEK, XDH |
4.66932 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, INSR, MET, PIK3CA, PIK3CB, SRC, TEK |
4.66932 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EBP, EGFR, ESR1, FLT3, INSR, KDR, PIK3CA, PPARA, SMAD3, SRC, TEK |
4.66932 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, MGLL, PTGS1, PTGS2, TBXAS1 |
4.60672 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, EGFR, ESR1, PPARA, PRKCG, RORC, SRC, TOP2A |
4.60664 |
[BP] GO:0006855 |
None
|
EBP, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
4.58537 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, PPARA, PRKCD, PRKCE, PTGS2, RORC, SRC, TEK |
4.58491 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, AURKB, BCL2, CDC25B, EGFR, ESR1, ESR2, FLT3, HSPA1A, INSR, JAK2, MET, MMP9, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, PTPN1, SMAD3, SRC, TEK, XDH |
4.58491 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, BCL2, CDC25B, EGFR, FLT3, INSR, JAK2, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TEK, XDH |
4.56031 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.54057 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, EGFR, ESR1, GPR35, JAK2, KCNH2, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
4.53857 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
4.53841 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, PRKCD, SRC |
4.52241 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, XDH |
4.51019 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, AXL, BCL2, CA2, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, FLT3, INSR, JAK2, KDR, MCL1, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SMAD3, SRC, TEK |
4.49626 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, MGLL, PPARA, PTGS1, PTGS2, TBXAS1 |
4.47254 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.43483 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, EGFR, HSPA1A, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SMAD3, SRC, TEK, TRPV1 |
4.34938 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, EGFR, KDR, PIK3CB, PRKCE, PTGS2, SRC, TRPV1 |
4.33934 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, MCL1, PIK3CA, SRC |
4.33453 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, AURKB, BCL2, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, FABP4, HSPA1A, IGF1R, KDR, MCL1, MET, MMP12, MMP9, PIK3CA, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH |
4.3265 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CHRM1, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TOP2A |
4.29529 |
[BP] GO:0036211 |
protein modification process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CHRM1, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TOP2A |
4.29529 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, PRKCD, PRKCE, PTGS2, SMAD3, SRC, TRPV1 |
4.24804 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CHRM1, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, JAK2, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TOP2A |
4.24245 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PRKCD, PRKCE |
4.24245 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, JAK2, PRKCD |
4.23615 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, JAK2, MMP2, MMP9, PTGS2 |
4.19932 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, AURKB, AXL, BCL2, CDC25B, CHRM1, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, JAK2, KCNH2, KDR, MET, MMP1, MMP2, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TOP2A |
4.19932 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, EGFR, JAK2, PPARA, SMAD3 |
4.19932 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
4.19932 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.11439 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC, TEK |
4.09871 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SMAD3, SRC, XDH |
4.06825 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, JAK2, PRKCA, PRKCE, SLC22A1 |
4.06612 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, JAK2, MCL1, MMP9, PIK3CB, PRKCD, PTGS2, SMAD3, SRC, TOP2A, TRPV1, XDH |
4.06612 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
BCL2, JAK2, KDR, PIK3CB, PRKCE, SMAD3, SRC, TEK |
4.05557 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.03655 |
[BP] GO:1903426 |
None
|
EGFR, INSR, JAK2, PTGS2, SMAD3, TRPV1 |
4.02943 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, JAK2, MCL1, MMP9, PIK3CB, PRKCD, PTGS2, SMAD3, SRC, TOP2A, TRPV1, XDH |
4.02802 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, MCL1, MET, PIK3CA, PPARA, PRKCG, SMAD3 |
3.97173 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
3.93045 |
[BP] GO:0043412 |
macromolecule modification
|
ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CHRM1, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TOP2A |
3.92243 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, EGFR, ESR1, GPR35, JAK2, KCNH2, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
3.92243 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, JAK2, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TEK |
3.91541 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, GPR35, KCNH2, MMP9, PRKCE, PTGS2 |
3.82444 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, GLO1, GPR35, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A1, SLC22A2, SLC22A3, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
3.8223 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, INSR, PPARA, PRKCD, PTGS2, SRC, TEK, TRPV1 |
3.79299 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, EGFR, FLT3, INSR, JAK2, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TEK |
3.76699 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, APEX1, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, HSPA1A, JAK2, MCL1, MMP9, NUAK1, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TOP2A, TRPV1 |
3.76699 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, KDR, PRKCE, SRC, TRPV1 |
3.76178 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, AXL, BCL2, CA2, CYP19A1, DUSP3, ESR1, HSPA1A, JAK2, MMP12, MMP2, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SMAD3, SRC |
3.76178 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, JAK2, KDR, MCL1, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
3.74993 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, MCL1, PIK3CA, SRC |
3.74544 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
AXL, BCL2, CA2, CYP1B1, EGFR, HSPA1A, JAK2, KDR, MET, MMP12, MMP9, PIM1, PRKCA, PRKCB, PRKCE, PTGS2, SMAD3, SRC, TEK, TRPV1 |
3.74436 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, AURKB, BCL2, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PRKCA, SMAD3, TOP2A |
3.72155 |
[BP] GO:0015893 |
None
|
CA2, EBP, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
3.71222 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, JAK2, KDR, MCL1, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
3.71222 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, JAK2, MCL1, MMP9, PIK3CB, PRKCD, PTGS2, SMAD3, SRC, TOP2A, TRPV1, XDH |
3.71222 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, INSR, PRKCA, PRKCE, SRC |
3.69257 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, JAK2, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TEK |
3.67853 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TEK |
3.67831 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, AURKB, BCL2, CSNK2A1, DUSP3, ESR1, ESR2, FABP4, HSPA1A, IGF1R, MCL1, MET, MMP12, MMP9, PIK3CA, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH |
3.66365 |
[BP] GO:0031329 |
regulation of cellular catabolic process
|
APEX1, BCL2, HSPA1A, INSR, KDR, MCL1, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCG, PTPN1 |
3.64131 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, AURKB, BCL2, CDC25B, EGFR, ESR1, FLT3, HSPA1A, INSR, JAK2, PIK3CA, PIK3CB, PRKCD, PRKCE, PTPN1, SMAD3, SRC, TEK, XDH |
3.63914 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, BCL2, CA2, CA7, ESR1, GPR35, JAK2, MCL1, PIK3CA, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
3.62539 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, JAK2, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
3.60789 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, JAK2, MCL1, MMP9, PRKCD, PTGS2, PTPN1, SMAD3, SRC |
3.60304 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, PRKCA, PRKCE, PTGS2, SMAD3, SRC, TOP2A |
3.57286 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, EGFR, FLT3, INSR, JAK2, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TEK |
3.56585 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MGLL, PPARA, PTGS1, PTGS2, TBXAS1 |
3.56412 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.55639 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MCL1, MMP9, PTGS2, PTPN1, SRC |
3.55639 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, PIK3CB, SMAD3, SRC, TEK |
3.52894 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
3.4924 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CHRM1, EGFR, JAK2, MMP12, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC |
3.4881 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, EGFR, IGF1R, INSR, MMP2, PRKCD, PTGS2, SRC, TRPV1 |
3.4881 |
[BP] GO:0050730 |
None
|
ADORA1, EGFR, FLT3, JAK2, PRKCD, PRKCE, PTPN1, SRC |
3.4829 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
3.46763 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, CHRM1, JAK2, MET, PRKCA, PRKCD, PRKCE, SLC22A2, XDH |
3.44603 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, PRKCD |
3.44399 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, EGFR, INSR, JAK2, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
3.43533 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, JAK2, PIK3CB, PRKCD, PTPN1, SRC |
3.39412 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EBP, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, GLO1, GPR35, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
3.39412 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, EGFR, FUT7, JAK2, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCD, SRC, TEK |
3.37187 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, PRKCD, SMAD3, TEK |
3.36186 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APEX1, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
3.32843 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, EGFR, FLT3, INSR, JAK2, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
3.31413 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
3.31052 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1, RORC |
3.31052 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, BCL2, CHRM1, EGFR, JAK2, MMP12, PRKCD, PRKCE, PTGS2, SMAD3, SRC |
3.31052 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, JAK2, PIM1, PPARA, RORC, SRC |
3.30764 |
[BP] GO:0031349 |
positive regulation of defense response
|
EGFR, FABP4, HSPA1A, JAK2, MMP12, MMP2, PRKCD, PRKCE, PTGS2, SRC |
3.30764 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, EGFR, ESR1, GPR35, JAK2, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
3.30764 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EBP, ESR1 |
3.30489 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, PRKCD, SMAD3, TEK |
3.29655 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.27573 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
3.26856 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, PRKCE |
3.24114 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, HSPA1A, MGLL, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
3.23442 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, EGFR, IGF1R, INSR, MMP2, PRKCD, PTGS2, SRC, TRPV1 |
3.2278 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PRKCA, PTGS2, TEK |
3.2013 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, EGFR, PRKCE, PTGS2 |
3.1793 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, JAK2, MET, MMP9, PPARA, PRKCD, SMAD3, SRC |
3.16705 |
[BP] GO:0019371 |
None
|
PTGS1, PTGS2, TBXAS1 |
3.15403 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC, TEK |
3.13866 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.13866 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
DUSP3, EGFR, HSPA1A, IGF1R, MCL1, MET, NUAK1, PRKCD, PRKCG, PTGS2, PTPN1, XDH |
3.13314 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, INSR, JAK2, PIK3CB, PTPN1, SRC |
3.11923 |
[BP] GO:0055065 |
metal ion homeostasis
|
BCL2, EGFR, ESR1, GPR35, JAK2, KCNH2, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
3.11153 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, ESR1, GPR35, JAK2, PIK3CA, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
3.11052 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, EGFR, FUT7, JAK2, KDR, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCD, SRC, TEK |
3.06498 |
[BP] GO:0050776 |
regulation of immune response
|
BCL2, DUSP3, ESR1, HSPA1A, JAK2, MMP12, MMP2, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, PTPN1, SMAD3, SRC |
3.06498 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, JAK2, MMP2, MMP9, PTGS2 |
3.06114 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, EBP, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2 |
3.06047 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, MGLL |
3.05919 |
[BP] GO:0015872 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.05174 |
[BP] GO:0015697 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.05174 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, KCNH2, PPARA, PRKCB, PRKCE, SLC22A1, SLC22A2, SLC22A3, SLC47A1, TRPV1 |
3.03755 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
EGFR, JAK2, PRKCD, PTGS2, SMAD3, SRC |
3.03446 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, JAK2, PPARA, RORC, SRC |
3.03446 |
[BP] GO:0097190 |
apoptotic signaling pathway
|
ADORA1, BCL2, CYP1B1, JAK2, MCL1, PRKCA, PRKCD, SMAD3 |
3.02344 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
AURKB, AXL, BCL2, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PRKCD, PRKCE, SMAD3, SRC, TEK |
3.00997 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD |
2.99454 |
[BP] GO:0035408 |
None
|
PRKCA, PRKCB |
2.99183 |
[BP] GO:0015695 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1 |
2.98606 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, ESR1, GPR35, JAK2, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
2.98144 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, EGFR, FUT7, JAK2, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCD, SRC, TEK |
2.98101 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, FABP4, JAK2, KDR, MET, PRKCA, PTGS2, SMAD3 |
2.97947 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
CA2, CA7, PRKCE |
2.95945 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.94854 |
[BP] GO:0038128 |
None
|
EGFR, PIK3CA, PRKCA, SRC |
2.94788 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3, JAK2 |
2.94184 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SRC |
2.92844 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, EGFR, JAK2, KCNH2, PTGS2 |
2.92045 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, JAK2, MMP9, PTGS2, SMAD3, SRC, XDH |
2.91727 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, ESR1, GPR35, JAK2, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
2.89709 |
[BP] GO:0034097 |
response to cytokine
|
AXL, BCL2, FABP4, FLT3, JAK2, MCL1, PRKCA, PTGS2, SRC, TRPV1 |
2.8758 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.86824 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
BCL2, ESR1, GPR35, JAK2, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
2.86449 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, HSPA1A, MCL1, MMP9, PTGS2, PTPN1, SRC |
2.85898 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, JAK2, MMP12, PRKCE, SRC, TRPV1 |
2.85898 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, CHRM1, EGFR, JAK2, MMP12, PRKCD, PRKCE, PTGS2, SMAD3, SRC |
2.85898 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, GLO1, GPR35, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.85898 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD |
2.84708 |
[BP] GO:0010595 |
positive regulation of endothelial cell migration
|
KDR, MET, PRKCA, PTGS2, TEK |
2.84708 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, PRKCD, PRKCG, SRC |
2.84191 |
[BP] GO:0070201 |
None
|
ACHE, BCL2, CHRM1, EGFR, JAK2, MMP12, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC |
2.84191 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ESR1, HSPA1A, KDR, MET, MMP1, PRKCA, PRKCE, SMAD3, SRC, TEK |
2.82976 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, CDC25B, CYP1A1, DUSP3, INSR, PRKCA |
2.82525 |
[BP] GO:0051937 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.78921 |
[BP] GO:0055074 |
calcium ion homeostasis
|
BCL2, ESR1, GPR35, JAK2, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
2.7766 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, PTGS2, SRC |
2.77167 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.76394 |
[BP] GO:0045321 |
leukocyte activation
|
ALOX5, AXL, BCL2, FLT3, FUT7, HSPA1A, MMP9, PRKCB, PRKCD, PRKCE, RORC, SMAD3, TRPV1 |
2.76002 |
[BP] GO:0051128 |
regulation of cellular component organization
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PIK3CB, PRKCD, PRKCE, PRKCG, PTPN1, SMAD3, SRC, TEK, TOP2A |
2.76002 |
[BP] GO:1903827 |
regulation of cellular protein localization
|
BCL2, CHRM1, CSNK2A1, EGFR, JAK2, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC |
2.7432 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
BCL2, ESR1, GPR35, JAK2, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
2.74059 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, CHRM1, GPR35, KCNH2, MMP9, PRKCD, PRKCE, PTGS2 |
2.73896 |
[BP] GO:1903829 |
positive regulation of cellular protein localization
|
BCL2, CHRM1, EGFR, JAK2, PRKCD, PRKCE, PTGS2, SMAD3, SRC |
2.72702 |
[BP] GO:0032075 |
None
|
HSPA1A, PRKCD, PTPN1 |
2.71854 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.71854 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.71854 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, AXL, BCL2, CDC25B, CYP1A1, EGFR, ESR1, FABP4, FLT3, FUT7, GLO1, JAK2, KDR, MCL1, MET, MMP2, MMP9, PRKCD, PTGS2, RORC, SMAD3, SRC, TEK, TOP2A |
2.71356 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A1, SLC22A2, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, XDH |
2.70521 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
AURKB, BCL2, HSPA1A, INSR, KDR, MET, MMP9, PRKCE, SMAD3, SRC, TEK |
2.70495 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, CSNK2A1, EGFR, FABP3, FABP4, MET, MGLL, PIK3CA, PIK3CB |
2.70341 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
CYP1B1, KDR, PRKCA, PRKCB, PTGS2, TEK |
2.6861 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, PTGS2, SRC |
2.67254 |
[BP] GO:0003018 |
None
|
ADORA1, CHRM1, EGFR, PTGS2, SRC, TEK |
2.67254 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.62283 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, EBP, EGFR, FABP3, HSPA1A, JAK2, KCNH2, MCL1, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TRPV1, XDH |
2.6222 |
[BP] GO:0046649 |
lymphocyte activation
|
AXL, BCL2, FLT3, FUT7, PRKCB, PRKCD, RORC, SMAD3 |
2.61541 |
[BP] GO:0035306 |
None
|
ADORA1, JAK2, PRKCD, SMAD3 |
2.61176 |
[BP] GO:0046626 |
regulation of insulin receptor signaling pathway
|
PRKCB, PRKCD, PTPN1, SRC |
2.61176 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, JAK2, KDR, TEK |
2.61176 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, KDR, MMP2, PRKCE, PTGS2, SRC |
2.6028 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, JAK2, MMP9, PTGS2, SMAD3, SRC, XDH |
2.59949 |
[BP] GO:0042307 |
positive regulation of protein import into nucleus
|
EGFR, JAK2, PRKCD, PTGS2, SMAD3 |
2.59838 |
[BP] GO:0042752 |
None
|
ADORA1, PPARA, PRKCG, RORC, TOP2A |
2.59838 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.59838 |
[BP] GO:0072488 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.58879 |
[BP] GO:0051172 |
None
|
APEX1, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, FABP4, HSPA1A, IGF1R, MMP12, MMP9, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH |
2.58758 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, EBP, EGFR, ESR1, FABP3, HSPA1A, JAK2, KCNH2, MCL1, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TRPV1, XDH |
2.57184 |
[BP] GO:1904591 |
positive regulation of protein import
|
EGFR, JAK2, PRKCD, PTGS2, SMAD3 |
2.56515 |
[BP] GO:0045088 |
regulation of innate immune response
|
ESR1, HSPA1A, JAK2, MMP12, MMP2, PRKCD, PRKCE, PTPN1, SRC |
2.56421 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3 |
2.55264 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.55264 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.55264 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.55264 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.55264 |
[BP] GO:0010676 |
None
|
INSR, PPARA, PRKCE, SRC |
2.53693 |
[BP] GO:0050994 |
None
|
ADORA1, PPARA, PRKCD, PRKCE |
2.53693 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.53536 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1, PTGS2, TBXAS1, XDH |
2.53536 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, BCL2, CHRM1, CSNK2A1, EGFR, JAK2, MMP12, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC |
2.53493 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.53355 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, JAK2, PPARA, RORC, SRC |
2.53355 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, AXL, MGLL, PIK3CA, PIK3CB, PTGS1, PTGS2, TRPV1 |
2.50129 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.48007 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.48007 |
[BP] GO:0051223 |
None
|
ACHE, CHRM1, EGFR, JAK2, MMP12, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC |
2.47294 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, EBP, FABP3, HSPA1A, JAK2, KCNH2, MCL1, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TRPV1, XDH |
2.47262 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.46935 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP9, TRPV1 |
2.46835 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
JAK2, KDR, PRKCE, SMAD3, TEK |
2.46835 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
APEX1, EGFR, ESR1, FLT3, INSR, PRKCD, PRKCE, SRC |
2.45121 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.45088 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
CSNK2A1, HSPA1A, INSR, KDR, PIK3CB, PPARA, PRKCD, PRKCE, PTPN1 |
2.43648 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, KDR, PRKCA, PRKCB, PTGS2, TEK |
2.43552 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1 |
2.43552 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, JAK2, MMP12, PRKCE, SRC |
2.43323 |
[BP] GO:2001235 |
positive regulation of apoptotic signaling pathway
|
BCL2, JAK2, MCL1, MMP9, PRKCD, SMAD3 |
2.42476 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.41916 |
[BP] GO:0015844 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.41916 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.41916 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, EGFR, ESR1, ESR2, FABP3, IGF1R, INSR, JAK2, KDR, MET, MMP12, PPARA, PRKCD, PTGS2, RORC, SMAD3, SRC, TOP2A, TRPV1 |
2.41133 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.40683 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, PRKCE, SRC |
2.40336 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, FLT3, INSR, JAK2, PIK3CB, PTPN1, SRC |
2.39587 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, MMP9, RORC |
2.38051 |
[BP] GO:0009888 |
tissue development
|
ALPL, CYP1B1, INSR, JAK2, KDR, PIK3CA, PPARA, PTGS2, RORC, SMAD3 |
2.37172 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.36709 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
JAK2, MMP2, MMP9 |
2.36709 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.36709 |
[BP] GO:0050996 |
None
|
PPARA, PRKCD, PRKCE |
2.36709 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, BCL2, CHRM2, CYP1A1, CYP1A2, JAK2, MMP12, PRKCD, PTGS2, SMAD3, SRC |
2.36584 |
[BP] GO:1901374 |
None
|
SLC22A1, SLC22A2 |
2.35518 |
[BP] GO:0015874 |
None
|
SLC22A1, SLC22A2 |
2.35518 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.35518 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1 |
2.32506 |
[BP] GO:2001267 |
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway
|
JAK2, MMP9, SMAD3 |
2.31774 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM4 |
2.31774 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.31774 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM4 |
2.31774 |
[BP] GO:1901215 |
negative regulation of neuron death
|
AXL, BCL2, JAK2, PIK3CA, PPARA, PRKCG |
2.31686 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, FABP4, HSPA1A, IGF1R, KDR, MMP12, MMP9, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH |
2.31686 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
AXL, CYP1B1, EGFR, FUT7, JAK2, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PTGS2, SRC, TEK |
2.29505 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, MET, PIK3CA, TRPV1 |
2.28313 |
[BP] GO:0048731 |
system development
|
ACHE, ADORA1, ALPL, CHRM1, CHRM2, EBP, MMP9, PIK3CA, SMAD3, SRC, TEK |
2.27716 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
DUSP3, EGFR, KDR, PRKCA, PTPN1, SRC, TEK |
2.26936 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.2691 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.2691 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, JAK2, PTGS2, SRC |
2.24453 |
[BP] GO:0010675 |
None
|
INSR, PPARA, PRKCE, RORC, SRC |
2.2389 |
[BP] GO:1901214 |
regulation of neuron death
|
AXL, BCL2, JAK2, MCL1, PIK3CA, PPARA, PRKCG |
2.23662 |
[BP] GO:0043523 |
regulation of neuron apoptotic process
|
AXL, BCL2, JAK2, MCL1, PIK3CA, PRKCG |
2.22822 |
[BP] GO:0019433 |
None
|
FABP3, FABP4, MGLL |
2.22103 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, BCL2, CHRM2, CYP1A1, CYP1A2, JAK2, MMP12, PRKCD, PTGS2, SMAD3, SRC |
2.21899 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.21899 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, PTGS2 |
2.21899 |
[BP] GO:0051248 |
None
|
CSNK2A1, DUSP3, EGFR, FABP4, HSPA1A, IGF1R, MMP9, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SMAD3, SRC, XDH |
2.21899 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
BCL2, ESR1, GPR35, JAK2, PIK3CB, PRKCB, PRKCE, SMAD3, TRPV1 |
2.201 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, INSR, PTGS2, SRC |
2.19749 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, JAK2, KDR, TEK |
2.19736 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.18389 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.17773 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
PRKCB, PRKCD, PTPN1, SRC |
2.17454 |
[BP] GO:0046618 |
None
|
SLC47A1, SLC47A2 |
2.16626 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, MGLL, PIM1, PPARA, PTGS1, PTGS2, TBXAS1 |
2.1555 |
[BP] GO:0045913 |
None
|
INSR, PPARA, PRKCE, SRC |
2.1555 |
[BP] GO:0035304 |
regulation of protein dephosphorylation
|
ADORA1, JAK2, NUAK1, PRKCD |
2.1555 |
[BP] GO:0045785 |
positive regulation of cell adhesion
|
JAK2, KDR, PIK3CA, PRKCA, PRKCE, SMAD3, SRC, TEK |
2.15111 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, CYP1B1, ESR1, ESR2, HSPA1A, JAK2, PIM1, PRKCB |
2.14515 |
[BP] GO:0051052 |
regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, INSR, PIK3CA, PRKCD, PRKCG, SRC |
2.14515 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, BCL2, GPR35, HSPA1A, KCNH2, MMP9, PRKCB, PRKCE, PTGS2 |
2.1426 |
[BP] GO:0032069 |
None
|
HSPA1A, PRKCD, PTPN1 |
2.13972 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM4 |
2.13972 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.13761 |
[BP] GO:0003013 |
None
|
ADORA1, CHRM1, EGFR, PTGS2, SRC, TEK |
2.12272 |
[BP] GO:0038096 |
Fc-gamma receptor signaling pathway involved in phagocytosis
|
PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
2.12272 |
[BP] GO:0002433 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis
|
PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
2.12272 |
[BP] GO:0002684 |
positive regulation of immune system process
|
AXL, BCL2, CA2, HSPA1A, MMP12, MMP2, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, SRC |
2.10591 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, JAK2, PTGS2, SRC |
2.10048 |
[BP] GO:0010507 |
negative regulation of autophagy
|
BCL2, MCL1, MET, PIK3CA |
2.09778 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, IGF1R, INSR, PRKCD, SRC |
2.09752 |
[BP] GO:0002431 |
Fc receptor mediated stimulatory signaling pathway
|
PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
2.09752 |
[BP] GO:0038094 |
Fc-gamma receptor signaling pathway
|
PIK3CA, PIK3CB, PRKCD, PRKCE, SRC |
2.0679 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, EGFR, ESR1, ESR2, FABP3, IGF1R, INSR, JAK2, MET, MMP12, PPARA, PRKCD, PTGS2, RORC, SMAD3, SRC, TOP2A, TRPV1 |
2.0656 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, EGFR, PRKCE, PTGS2 |
2.06333 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, EGFR, PRKCE, PTGS2 |
2.06333 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.05844 |
[BP] GO:0050793 |
regulation of developmental process
|
AXL, BCL2, CA2, CYP1B1, EGFR, ESR1, INSR, JAK2, KDR, NUAK1, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PTGS2, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
2.05498 |
[BP] GO:0035239 |
tube morphogenesis
|
BCL2, EGFR, ESR1, MET, SMAD3, SRC |
2.02805 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.02568 |
[BP] GO:0046627 |
None
|
PRKCB, PRKCD, PTPN1 |
2.02568 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.02568 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.02568 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.02568 |
[BP] GO:0043524 |
negative regulation of neuron apoptotic process
|
AXL, BCL2, JAK2, PIK3CA, PRKCG |
2.02369 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, PTGS2 |
2.01071 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4 |
2.00523 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.00523 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CSNK2A1, EGFR, ESR1, FLT3, GLO1, GPR35, IGF1R, INSR, JAK2, KCNH2, KDR, MET, MGLL, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SMAD3, SRC, TEK, TRPV1 |
7.84079 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EBP, EGFR, ESR1, FLT3, FUT7, GLO1, GPR35, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MET, MGLL, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SMAD3, SRC, TBXAS1, TEK, TRPV1 |
6.01015 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, EGFR, INSR, JAK2, MET, PRKCG, PTGS2, SLC22A1, SRC, TEK, TRPV1 |
4.49626 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, DUSP3, EBP, EGFR, FLT3, GPR35, IGF1R, INSR, JAK2, KCNH2, KDR, MET, PRKCG, PTGS2, SLC22A1, SLC22A2, SLC22A3, SRC, TEK, TRPV1 |
4.08983 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, FLT3, FUT7, GPR35, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MET, MGLL, PIK3CA, PIK3CB, PRKCG, PTGS1, PTGS2, PTPN1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SRC, TBXAS1, TEK, TRPV1 |
3.80039 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, AXL, CA4, CHRM1, CHRM2, CHRM4, EBP, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC22A1, SLC22A2, SLC22A3, TEK, TRPV1 |
3.46901 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, BCL2, CA4, CYP19A1, EBP, FLT3, HSPA1A, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, XDH |
3.44399 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, EBP, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC22A1, SLC22A2, SLC22A3, TEK, TRPV1 |
3.17273 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, SLC22A1, TEK |
3.15403 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, CA4, EGFR, HSPA1A, KCNH2, PRKCA, PRKCD, PRKCE, PRKCG, SRC |
3.14919 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, AURKB, BCL2, CA1, CA2, CA4, CA7, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, HSPA1A, INSR, JAK2, KCNH2, KDR, MCL1, MGLL, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TBXAS1, TOP2A, TRPV1, XDH |
2.5577 |
[CC] GO:0045121 |
membrane raft
|
EGFR, INSR, JAK2, KDR, PTGS2, SRC, TEK |
2.12272 |
[CC] GO:0098857 |
membrane microdomain
|
EGFR, INSR, JAK2, KDR, PTGS2, SRC, TEK |
2.10783 |
[CC] GO:0005901 |
caveola
|
INSR, JAK2, PTGS2, SRC |
2.09778 |
[CC] GO:0044464 |
cell part
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MCL1, MET, MGLL, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, XDH |
2.06712 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.02568 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, APEX1, AURKB, AXL, BCL2, CA1, CA2, CA4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, JAK2, KDR, MCL1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SLC47A1, SMAD3, SRC, TOP2A, XDH |
2.01785 |
[CC] GO:0005654 |
None
|
AKR1B1, ALOX5, APEX1, AURKB, BCL2, CDC25B, CSNK2A1, DUSP3, ESR1, ESR2, HSPA1A, JAK2, MCL1, MGLL, NQO2, NUAK1, PIM1, PPARA, PRKCA, PRKCB, PRKCD, RORC, SMAD3, SRC, TOP2A |
2.00543 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, SMAD3, TBXAS1, XDH |
12.1205 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EBP, EGFR, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, JAK2, KCNH2, KDR, MET, MGLL, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SRC, TBXAS1, TEK, TOP2A, XDH |
11.7253 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 |
11.0308 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, XDH |
10.0033 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.0033 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK |
10.0033 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK |
9.48568 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, JAK2, PIK3CA, PIK3CB, PRKCD |
8.9149 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK |
8.87232 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, SMAD3 |
8.48137 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK |
7.68596 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.25219 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, JAK2, KDR, MET, PRKCD, SRC, TEK |
7.19155 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, GLO1, JAK2, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, TBXAS1, TOP2A, TRPV1, XDH |
6.69835 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.67245 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.51956 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APEX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, GLO1, JAK2, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, TBXAS1, TOP2A, TRPV1, XDH |
6.43811 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 |
6.3215 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, JAK2, PTGS1, PTGS2, SRC, TBXAS1 |
6.26226 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.26226 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 |
6.1721 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 |
6.12434 |
[MF] GO:0004697 |
None
|
PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
6.06682 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, JAK2, PTGS1, PTGS2, SRC, TBXAS1 |
6.01958 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1, XDH |
5.34068 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.09189 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, IGF1R, INSR, JAK2, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SRC, TEK |
5.0597 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, EBP, EGFR, ESR1, ESR2, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK, TRPV1 |
4.98435 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1, XDH |
4.89991 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1, XDH |
4.89841 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 |
4.88097 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 |
4.71526 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, EBP, EGFR, ESR1, ESR2, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, PPARA, PRKCE, RORC, SMAD3, TEK, TRPV1 |
4.70822 |
[MF] GO:0017076 |
purine nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 |
4.67274 |
[MF] GO:0032553 |
ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 |
4.66932 |
[MF] GO:0004698 |
None
|
PRKCA, PRKCB, PRKCG |
4.54057 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, BCL2, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, JAK2, KCNH2, KDR, MCL1, MET, MGLL, MMP9, NQO2, PTGS2, SLC22A1, SMAD3, TOP2A, TRPV1, XDH |
4.49626 |
[MF] GO:0035173 |
histone kinase activity
|
AURKB, JAK2, PRKCA, PRKCB |
4.23615 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, EBP, EGFR, ESR1, ESR2, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK, TRPV1 |
4.22805 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
4.19932 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ADORA1, AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1 |
4.14943 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, EBP, EGFR, ESR1, ESR2, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK, TRPV1 |
4.03286 |
[MF] GO:0043168 |
anion binding
|
AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK, TOP2A, TRPV1, XDH |
3.93489 |
[MF] GO:0005329 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.93045 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC |
3.80408 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, CSNK2A1, EGFR, NUAK1, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
3.75686 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.74544 |
[MF] GO:0015238 |
None
|
EBP, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
3.72155 |
[MF] GO:0019899 |
enzyme binding
|
AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, ESR2, HSPA1A, JAK2, KCNH2, MET, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A |
3.60034 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TBXAS1 |
3.60034 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC |
3.58904 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.55875 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, JAK2, NQO2, PTGS1, PTGS2, SRC, TBXAS1, XDH |
3.53596 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1, XDH |
3.52495 |
[MF] GO:0008504 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.40454 |
[MF] GO:0015651 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
3.40454 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.40454 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR, JAK2 |
3.39412 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1, PTGS2, TBXAS1, XDH |
3.31448 |
[MF] GO:0009931 |
None
|
PRKCA, PRKCB, PRKCG |
3.15403 |
[MF] GO:0019900 |
None
|
AURKB, CDC25B, DUSP3, EGFR, ESR1, JAK2, PRKCB, PRKCD, PTPN1, SMAD3, SRC, TOP2A |
3.07224 |
[MF] GO:0010857 |
None
|
PRKCA, PRKCB, PRKCG |
3.05174 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESR2, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, MMP12, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, XDH |
3.05008 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.99183 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.99183 |
[MF] GO:0035403 |
None
|
PRKCA, PRKCB |
2.99183 |
[MF] GO:0019901 |
None
|
CDC25B, DUSP3, EGFR, ESR1, JAK2, PRKCB, PRKCD, PTPN1, SMAD3, SRC, TOP2A |
2.91662 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESR2, FLT3, HSPA1A, IGF1R, INSR, JAK2, KDR, MET, MMP12, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, XDH |
2.85275 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, IGF1R, INSR, NQO2 |
2.84708 |
[MF] GO:0035258 |
None
|
ESR1, FLT3, PRKCB, SMAD3, SRC |
2.78107 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.73572 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, EBP, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
2.71854 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM4, EBP, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
2.71854 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TBXAS1 |
2.64658 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, PPARA, RORC |
2.61176 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.61176 |
[MF] GO:0015307 |
None
|
SLC47A1, SLC47A2 |
2.59838 |
[MF] GO:1901375 |
None
|
SLC22A1, SLC22A2 |
2.59838 |
[MF] GO:0005333 |
None
|
SLC22A1, SLC22A2 |
2.59838 |
[MF] GO:0005277 |
None
|
SLC22A1, SLC22A2 |
2.59838 |
[MF] GO:0008513 |
None
|
SLC22A1, SLC22A2 |
2.59838 |
[MF] GO:0004699 |
None
|
PRKCD, PRKCE |
2.59838 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.58879 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, MET, PPARA, PTPN1, SMAD3 |
2.56421 |
[MF] GO:0051427 |
hormone receptor binding
|
ESR1, FLT3, JAK2, PRKCB, SMAD3, SRC |
2.46935 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.43552 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, BCL2, FLT3, KCNH2, MCL1, MGLL, NQO2, PTGS2, SLC22A1, SMAD3, TOP2A, XDH |
2.42786 |
[MF] GO:0016740 |
transferase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, FUT7, IGF1R, INSR, JAK2, KCNH2, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TEK |
2.38328 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.35824 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.35518 |
[MF] GO:0015101 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.2691 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.26389 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, AXL, BCL2, EGFR, FLT3, KCNH2, MCL1, MGLL, NQO2, PTGS2, SLC22A1, SMAD3, TOP2A, XDH |
2.22603 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.19736 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.16626 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.16626 |
[MF] GO:0051434 |
BH3 domain binding
|
BCL2, MCL1 |
2.16626 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.13761 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.12272 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPL, APEX1, CA1, CA2, CDC25B, CHRM1, DUSP3, MGLL, PTPN1 |
2.05909 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.03723 |
[MF] GO:0008519 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.02568 |
[MF] GO:0055131 |
None
|
HSPA1A, KCNH2 |
2.02568 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.02568 |